RHONE POULENC RORER LTD has a total of 366 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and medical technology are ZACH SYSTEM SPA, PURISYS LLC and LAFON VICTOR.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 63 | |
#2 | WIPO (World Intellectual Property Organization) | 43 | |
#3 | Australia | 32 | |
#4 | EPO (European Patent Office) | 31 | |
#5 | Israel | 28 | |
#6 | South Africa | 27 | |
#7 | Canada | 23 | |
#8 | United States | 23 | |
#9 | Ireland | 13 | |
#10 | New Zealand | 11 | |
#11 | Finland | 10 | |
#12 | Hungary | 10 | |
#13 | Mexico | 10 | |
#14 | Czechia | 9 | |
#15 | Norway | 8 | |
#16 | Poland | 7 | |
#17 | Portugal | 4 | |
#18 | Slovakia | 4 | |
#19 | Japan | 3 | |
#20 | Brazil | 2 | |
#21 | China | 1 | |
#22 | EAPO (Eurasian Patent Organization) | 1 | |
#23 | Republic of Korea | 1 | |
#24 | Russian Federation | 1 | |
#25 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Environmental technology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Syringes | |
#5 | Medical preparations | |
#6 | Steroids | |
#7 | Special acyclic compounds | |
#8 | Sugars | |
#9 | Milling | |
#10 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Trunley Roy | 60 |
#2 | Simpkin Gordon Thomas | 51 |
#3 | Fenton Garry | 50 |
#4 | Ratcliffe Andrew James | 49 |
#5 | Cook Robert Stanley | 45 |
#6 | Palfreyman Malcolm Norman | 45 |
#7 | Leighton Ann-Marie | 44 |
#8 | Hobbs Michael Anthony | 44 |
#9 | Morley Andrew David | 39 |
#10 | Harris Neil Victor | 36 |
Publication | Filing date | Title |
---|---|---|
GB9930698D0 | Chemical compounds | |
WO0032165A1 | Milling process for the production of finely milled medicinal substances | |
GB9922243D0 | Polynucleotides and polypeptides | |
GB9919693D0 | Process | |
GB9910409D0 | Chemical compounds | |
GB9910419D0 | Chemical compounds | |
GB9910405D0 | Chemical compounds | |
GB9910394D0 | Chemical compounds | |
GB9910396D0 | Chemical compounds | |
US6096768A | Compounds containing phenyl linked to aryl or heteroaryl by an aliphatic- or heteroatom-containing linking group | |
WO9954321A1 | Substituted diamines and their use as cell adhesion inhibitors | |
GB9908355D0 | Chemical compounds | |
GB9827721D0 | Chemical compounds | |
GB9722285D0 | Inhalation device | |
US6124343A | Substituted phenyl compounds with a substituent having a thienyl ring | |
GB9714831D0 | Chemical compounds | |
AU3453897A | Medicinal cyclosporin-a aerosol solution formulation | |
WO9748697A1 | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase | |
GB9704182D0 | Chemical compounds | |
GB9701264D0 | Chemical compounds |